In our patient, comprehensive cytogenetic and molecular characterization including Chromosomal Microarray Analysis (CMA) allowed showing association of the RCSD1-ABL1 fusion with the IKZF1 gene deletion, which is known as an adverse prognostic marker in B-ALL. Here, ABL1 is linked to acute lymphoblastic leukemia.